NCT07092397View on ClinicalTrials.gov

Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer

CompletedOBSERVATIONAL
Enrollment

266

Participants

Timeline

Start Date

April 5, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Gallbladder Cancer
Trial Locations (1)

06351

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER